Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Mar 25, 2023 8:52pm
184 Views
Post# 35360684

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.Hey Note, agree completely with you on this on, BUT that is if we get AA and if onc has applied for AA , neither of which we know for sure at this time.
Hopefully it will come to pass and end all speculation. As for the timing of a possible AA, that is the big question also. Did onc apply and when did they apply and how long does it take for this process and possible approval. With fast track in place hopefully sooner than later, I also believe that because of the indication that this would for sure be prioritized. But the big question is, did onc apply for AA.
Also the big kicker in all of this is if Matt made a slip in his latest podcast and let it slip that panc has more than 1 CR. Matt stated that we have complete responses that mean more than 1. Was he telling it like it is or was it a mistake. Usually Matt does not make mistakes when he talks so will be interesting to see what comes of this,cause if this is indeed true the slam dunk as no other panc trial has done this. But as with everything else with this company, we will just have to wait and see as no one on this or any board knows for sure what is, and what is going on.
<< Previous
Bullboard Posts
Next >>